Skip to main content
Figure 2 | Transplantation Research

Figure 2

From: Efficacy and safety of concentration-controlled everolimus with reduced-dose cyclosporine in Japanese de novo renal transplant patients: 12-month results

Figure 2

Mean everolimus and cyclosporine trough levels over time. (a) Mean everolimus trough levels over time for the everolimus 1.5 mg group (safety population). At each visit the mean is shown and these are joined with horizontal lines. Whiskers are the 5th and 95th percentiles. Target levels are displayed. (b) Mean cyclosporine trough levels for all treatment groups over time (safety population). At each visit the mean is shown and these are joined with horizontal lines. Whiskers are the 5th and 95th percentiles. The target ranges are also displayed with solid lines (lower limit) and broken lines (upper limit) for comparison with the values seen. MMF, mycophenolate mofetil.

Back to article page

Transplantation Research

ISSN: 2047-1440

Contact us